A new study shows the first promising therapy that can impact solid cancer tumors. The HPV-targeted adoptive T-cell therapy, boosts a cervical cancer patient's natural immune response to the virus by removing T-cells from the patient, growing it and putting them back in.
Life June 5, 2014
Genetic test as stand-alone cervical cancer screening test get FDA approval. Test approved as alternative to the long-standing Pap smear.
Life April 29, 2014
FDA recently approved a DNA-based HPV test for first option in cervical cancer screening. While HPV cannot be treated, early detection of cervix cell changes can save lives.
Life April 28, 2014